Amrutanjan Health Care Limited (IN:AMRUTANJAN)
:AMRUTANJAN
Want to see IN:AMRUTANJAN full AI Analyst Report?
AMRUTANJAN Stock Chart & Stats
₹671.50
-₹1.00(-0.14%)
At close: 4:00 PM EST
₹671.50
-₹1.00(-0.14%)
Day’s Range― - ―
52-Week Range₹490.00 - ₹789.95
Previous CloseN/A
Volume4.33K
Average Volume (3M)587.00
Market Cap
₹16.87B
Enterprise Value₹15.37B
Total Cash (Recent Filing)₹2.07B
Total Debt (Recent Filing)₹19.32M
Price to Earnings (P/E)24.8
Beta0.87
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.68%
Share Statistics
EPS (TTM)19.61
Shares Outstanding29,230,630
10 Day Avg. Volume607
30 Day Avg. Volume587
Financial Highlights & Ratios
PEG Ratio2.73
Price to Book (P/B)5.70
Price to Sales (P/S)4.13
P/FCF Ratio121.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetLow leverage, growing shareholders' equity and substantial cash reserves provide durable financial flexibility. This strength supports sustained marketing, distribution investment and selective M&A or capex without reliance on external debt, improving resilience to sector downturns.
Steady Revenue Growth And ProfitabilityConsistent top-line expansion and healthy gross and net margins across 2020–2025 indicate durable demand for core OTC products. Reliable profitability supports reinvestment in brands and distribution, enabling long-term market-share maintenance in consumer healthcare.
Positive Operating Cash FlowSustained operating cash conversion and disciplined capex enable internally funded growth and working capital needs. Over the medium term this underpins stable operations, reduces dependence on external financing and allows targeted reinvestment in marketing and distribution.
Bears Say
Inconsistent Free Cash FlowVolatile free cash flow can constrain capital allocation, limit consistent dividends or buybacks, and reduce the firm's margin for error during adverse periods. Inconsistency complicates long-term planning for expansion or sustained marketing investments.
Margin Volatility/cost Management ChallengesRecurring variability in operating margins signals exposure to input-cost swings or executional inefficiencies. Over months to years this can erode profitability, compress reinvestment capacity and increase vulnerability to competitive pricing pressure in OTC categories.
Concentration On Domestic OTC Retail ChannelsHeavy dependence on domestic branded OTC sales and retail/distributor reach concentrates revenue risk. Structural shifts in consumer behavior, retailer consolidation, or competitive brand gains could materially affect growth unless offset by geographic or channel diversification.
Amrutanjan Health Care Limited News
AMRUTANJAN FAQ
What was Amrutanjan Health Care Limited’s price range in the past 12 months?
Amrutanjan Health Care Limited lowest stock price was ₹490.00 and its highest was ₹789.95 in the past 12 months.
What is Amrutanjan Health Care Limited’s market cap?
Amrutanjan Health Care Limited’s market cap is ₹16.87B.
When is Amrutanjan Health Care Limited’s upcoming earnings report date?
Amrutanjan Health Care Limited’s upcoming earnings report date is May 21, 2026 which is in 15 days.
How were Amrutanjan Health Care Limited’s earnings last quarter?
Amrutanjan Health Care Limited released its earnings results on Feb 03, 2026. The company reported ₹6.731 earnings per share for the quarter, beating the consensus estimate of N/A by ₹6.731.
Is Amrutanjan Health Care Limited overvalued?
According to Wall Street analysts Amrutanjan Health Care Limited’s price is currently Overvalued.
Does Amrutanjan Health Care Limited pay dividends?
Amrutanjan Health Care Limited pays a Quarterly dividend of ₹1 which represents an annual dividend yield of 0.68%. See more information on Amrutanjan Health Care Limited dividends here
What is Amrutanjan Health Care Limited’s EPS estimate?
Amrutanjan Health Care Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amrutanjan Health Care Limited have?
Amrutanjan Health Care Limited has 29,230,630 shares outstanding.
What happened to Amrutanjan Health Care Limited’s price movement after its last earnings report?
Amrutanjan Health Care Limited reported an EPS of ₹6.731 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.052%.
Which hedge fund is a major shareholder of Amrutanjan Health Care Limited?
Currently, no hedge funds are holding shares in IN:AMRUTANJAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons and lotions, body pain gels, and joint muscle sprays, as well as diclofenac, a non-steroidal anti-inflammatory drug. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, South East Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Technical Analysis
Indoco Remedies Limited
―
Krsnaa Diagnostics Limited
―
TTK Healthcare Limited
―
Zota Health Care Ltd.
―